drugset / Trial / NCT02840279
A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a randomized, double-blind (Investigator and subject-blinded) placebo-controlled, multiple, ascending-dose study to evaluate the safety, tolerability, and pharmacokinetic profile of BPN14770 in healthy young and elderly male and female subjects and to provide a preliminary assessment of the cognitive effects of BPN14770 in healthy elderly subjects.
Timeline
- Start
- 2016-06
- Primary completion
- 2016-11
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | zatolmilast | Small molecule | — | Oral |